NEW YORK, Jan. 22 - Millennium Pharmaceuticals on Tuesday said that fourth-quarter losses widened as revenue fell and spending on new drug development increased.

Net loss for the quarter ended Dec. 31grew by 79 percent to $66.97 million, or 30 cents a share, from $37.49 million, or 18 cents, in the same period last year.